Celldex Therapeutics | CLDX - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -1.18 -1.19 -0.71 May/07
FY2025Q4 Dec/2025 -1.22 -1 -0.71 Feb/25
FY2025Q3 Sep/2025 -1.01 -0.9 -0.64 Nov/10
FY2025Q2 Jun/2025 -0.85 -0.80 -0.54 Aug/07
FY2025Q1 Mar/2025 -0.71 -0.76 -0.56 May/05




Eps Cambiamento Data
AbbVie USD 2.65 0.06 2026-03
Agenus USD -0.3 0.84 2025-12
Amgen USD 5.15 0.14 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Celldex Therapeutics USD -1.18 0.04 2026-03
Glaxosmithkline GBP 0.62 0.41 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Northwest Biotherapeutics USD -0.01 0.01 2025-09
Pfizer USD 0.75 0.09 2026-03
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Roche Holding CHF 8.37 2.95 2025-12